Back
Gritstone Bio Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
13
GRTS
Gritstone Bio
Last Price:
0.65
Seasonality Move:
-2.81%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
41.06
Seasonality Move:
-0.9%
Sell
13
Gritstone Bio (GRTS)
is a Sell
Is Gritstone Bio a Buy, Sell or Hold?
- The current Gritstone Bio [GRTS] share price is $0.71. The Score for GRTS is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- GRTS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRTS Stock Price Chart
What is Gritstone Bio's stock price today?
-
The Gritstone Bio share price today is $0.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRTS is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.42
The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRTS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 38.95 | Sell |
Chaikin Money Flow: | 42941 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.72 - 0.8) | Sell |
Bollinger Bands (100): | (0.64 - 2.22) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | 873891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Buy |
Bollinger Bands (100): | (40.78 - 48.78) | Sell |
GRTS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.73 | Sell |
20-day SMA: | 0.75 | Sell |
50-day SMA: | 0.79 | Sell |
200-day SMA: | 1.68 | Sell |
8-day EMA: | 0.73 | Sell |
20-day EMA: | 0.76 | Sell |
50-day EMA: | 0.93 | Sell |
200-day EMA: | 1.59 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.5 | Buy |
20-day SMA: | 40.58 | Buy |
50-day SMA: | 41.51 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 40.23 | Buy |
20-day EMA: | 40.49 | Buy |
50-day EMA: | 41.77 | Sell |
200-day EMA: | 43.33 | Sell |
Gritstone Bio Earnings Growth & GRTS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.27 per share, and an increase next year of $0.05 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Gritstone Bio Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |